Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
JSR hands over Crown to Carlyle-backed company in $204M deal
Adicon is paying $120 million upfront for the CRO, with payments of $40 million and $44 million to follow if certain conditions are met.
Darren Incorvaia
Nov 18, 2025 2:32pm
NIH cuts disrupted hundreds of clinical trials, study finds
Nov 17, 2025 11:00am
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
BMS boosts cancer trials with Sarah Cannon's platform
Nov 12, 2025 12:30pm
Charles River to cut costs, shift direction as revenue slides
Nov 5, 2025 12:54pm
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
